Tg Therapeutics (TGTX) Operating Income (2011 - 2026)
Tg Therapeutics' Operating Income came in at $21.67 million for Q2 2026, down 37.8% from $34.84 million a year earlier and down 37.7% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Operating Income (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Tg Therapeutics reported Operating Income of $136.33 million, up 58.8% year-over-year; for FY2025, it was $123.32 million, up 194.1% from FY2024.
- Going back by year, Operating Income was $41.93 million in FY2024 (+103.2%), $20.63 million in FY2023, -$218.32 million in FY2022 and -$344.77 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Operating Income since Q1 2025.
- Year-over-year, Operating Income increased in four of the last six quarters, with growth averaging 112.8%.
- Business Quant data shows TGTX's Operating Income at $34.8 million (Q1 2026), $50.49 million (Q4 2025) and $29.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Tg Therapeutics | 8.54 Bn | 7.93 Bn | 199.14 Mn | 21.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.67 Mn |
| Mar 31, 2026 | 34.80 Mn |
| Dec 31, 2025 | 50.49 Mn |
| Sep 30, 2025 | 29.37 Mn |
| Jun 30, 2025 | 34.84 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 29.95 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -12.49 Mn |
| Sep 30, 2023 | 114.78 Mn |
| Jun 30, 2023 | -44.67 Mn |
| Mar 31, 2023 | -36.99 Mn |
| Dec 31, 2022 | -77.54 Mn |
| Sep 30, 2022 | -34.96 Mn |
| Jun 30, 2022 | -38.94 Mn |
| Mar 31, 2022 | -66.87 Mn |
| Dec 31, 2021 | -92.95 Mn |
| Sep 30, 2021 | -85.13 Mn |
API Access
Tg Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();